Hamid Sayar, MD
Professor of Clinical Medicine
- Address
-
Indiana Cancer Pavilion, Suite 473
535 Barnhill Dr
RT 473
Indianapolis, IN 46202-5289 - PubMed:
-
| Year | Degree | Institution |
|---|---|---|
| 2010 | MS | Indiana University |
| 2007 | Fellowship | University of New Mexico School of Medicine, Albuquerque, NM |
| 2004 | Residency | University of Arizona College of Medicine, Tucson, AZ |
| 1992 | MD | Tehran University of Medical Sciences |
My focus is to develop novel therapeutic strategies against acute myeloid leukemia and myelodysplastic syndrome
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study.
Garcia-Manero G; Abaza Y; Takahashi K; Medeiros BC; Arellano M; Khaled SK; Patnaik M; Odenike O; Sayar H; Tummala M; Patel P; Maness-Harris L; Stuart R; Traer E; Karamlou K; Yacoub A; Ghalie R; Giorgino R; Atallah E; Blood advances 2019 Feb 26
Garcia-Manero G; Abaza Y; Takahashi K; Medeiros BC; Arellano M; Khaled SK; Patnaik M; Odenike O; Sayar H; Tummala M; Patel P; Maness-Harris L; Stuart R; Traer E; Karamlou K; Yacoub A; Ghalie R; Giorgino R; Atallah E; Blood advances 2019 Feb 26
Phase 3 results for vosaroxin/cytarabine in the subset of patients =60 years old with refractory/early relapsed acute myeloid leukemia.
Ravandi F; Ritchie EK; Sayar H; Lancet JE; Craig MD; Vey N; Strickland SA; Schiller GJ; Jabbour E; Pigneux A; Horst HA; Récher C; Klimek VM; Cortes JE; Carella AM; Egyed M; Krug U; Fox JA; Craig AR; Ward R; Smith JA; Acton G; Kantarjian HM; Stuart RK; 2018 May 24
Ravandi F; Ritchie EK; Sayar H; Lancet JE; Craig MD; Vey N; Strickland SA; Schiller GJ; Jabbour E; Pigneux A; Horst HA; Récher C; Klimek VM; Cortes JE; Carella AM; Egyed M; Krug U; Fox JA; Craig AR; Ward R; Smith JA; Acton G; Kantarjian HM; Stuart RK; 2018 May 24
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials.
Sayar H; Cripe LD; Saliba AN; Abu Zaid M; Konig H; Boswell HS; Leukemia research 2018 Dec 24
Sayar H; Cripe LD; Saliba AN; Abu Zaid M; Konig H; Boswell HS; Leukemia research 2018 Dec 24
Primary Myeloid Sarcoma of the Prostate: A Case Report and Literature Review.
Nguyen R; Sayar H; 2018 Apr 29
Nguyen R; Sayar H; 2018 Apr 29
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies.
Komrokji R; Swern AS; Grinblatt D; Lyons RM; Tobiasson M; Silverman LR; Sayar H; Vij R; Fliss A; Tu N; Sugrue MM; The oncologist 2017 Nov 8
Komrokji R; Swern AS; Grinblatt D; Lyons RM; Tobiasson M; Silverman LR; Sayar H; Vij R; Fliss A; Tu N; Sugrue MM; The oncologist 2017 Nov 8
Consecutive epigenetically-active agent combinations act in <i>ID1-RUNX3-TET2</i> and <i>HOXA</i> pathways for <i>Flt3ITD+ve</i> AML.
Sayar H; Liu Y; Gao R; Zaid MA; Cripe LD; Weisenbach J; Sargent KJ; Nassiri M; Li L; Konig H; Suvannasankha A; Pan F; Shanmugam R; Goswami C; Kapur R; Xu M; Boswell HS; 2017 Dec 25
Sayar H; Liu Y; Gao R; Zaid MA; Cripe LD; Weisenbach J; Sargent KJ; Nassiri M; Li L; Konig H; Suvannasankha A; Pan F; Shanmugam R; Goswami C; Kapur R; Xu M; Boswell HS; 2017 Dec 25
Therapies for acute myeloid leukemia: vosaroxin.
Sayar H; Bashardoust P; OncoTargets and therapy 2017 Aug 7
Sayar H; Bashardoust P; OncoTargets and therapy 2017 Aug 7
Chemotherapy-Related Chronic Myelogenous Leukemia: A Case Series of Patients With Germ Cell Tumor.
Adra N; Sayar H; Einhorn LH; JAMA oncology 2016 Mar
Adra N; Sayar H; Einhorn LH; JAMA oncology 2016 Mar
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia.
Roboz GJ; Montesinos P; Selleslag D; Wei A; Jang JH; Falantes J; Voso MT; Sayar H; Porkka K; Marlton P; Almeida A; Mohan S; Ravandi F; Garcia-Manero G; Skikne B; Kantarjian H; Future oncology (London, England) 2016 Jan 19
Roboz GJ; Montesinos P; Selleslag D; Wei A; Jang JH; Falantes J; Voso MT; Sayar H; Porkka K; Marlton P; Almeida A; Mohan S; Ravandi F; Garcia-Manero G; Skikne B; Kantarjian H; Future oncology (London, England) 2016 Jan 19
Long-term outcome of NPM1 mutated acute myeloid leukemia: A single-institution experience.
Sayar H; Bashardoust P; Cripe L; Chakraborty S; Bai S; American journal of hematology 2016 Dec 7
Sayar H; Bashardoust P; Cripe L; Chakraborty S; Bai S; American journal of hematology 2016 Dec 7
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
Ravandi F; Ritchie EK; Sayar H; Lancet JE; Craig MD; Vey N; Strickland SA; Schiller GJ; Jabbour E; Erba HP; Pigneux A; Horst HA; Recher C; Klimek VM; Cortes J; Roboz GJ; Odenike O; Thomas X; Havelange V; Maertens J; Derigs HG; Heuser M; Damon L; Powell BL; Gaidano G; Carella AM; Wei A; Hogge D; Craig AR; Fox JA; Ward R; Smith JA; Acton G; Mehta C; Stuart RK; Kantarjian HM; The Lancet. Oncology 2015 Jul 30
Ravandi F; Ritchie EK; Sayar H; Lancet JE; Craig MD; Vey N; Strickland SA; Schiller GJ; Jabbour E; Erba HP; Pigneux A; Horst HA; Recher C; Klimek VM; Cortes J; Roboz GJ; Odenike O; Thomas X; Havelange V; Maertens J; Derigs HG; Heuser M; Damon L; Powell BL; Gaidano G; Carella AM; Wei A; Hogge D; Craig AR; Fox JA; Ward R; Smith JA; Acton G; Mehta C; Stuart RK; Kantarjian HM; The Lancet. Oncology 2015 Jul 30
Acute Promyelocytic Leukemia Presenting with Severe Marrow Fibrosis.
Shah H; Bradford C; Sayar H; Case reports in hematology 2015 Jul 12
Shah H; Bradford C; Sayar H; Case reports in hematology 2015 Jul 12
Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia.
Khawaja MR; Perkins SM; Schwartz JE; Robertson MJ; Kiel PJ; Sayar H; Cox EA; Vance GH; Farag SS; Cripe LD; Nelson RP Jr; American journal of hematology 2015 Feb
Khawaja MR; Perkins SM; Schwartz JE; Robertson MJ; Kiel PJ; Sayar H; Cox EA; Vance GH; Farag SS; Cripe LD; Nelson RP Jr; American journal of hematology 2015 Feb
Pilot study of erlotinib in patients with acute myeloid leukemia.
Sayar H; Czader M; Amin C; Cangany M; Konig H; Cripe LD; Leukemia research 2014 Dec 2
Sayar H; Czader M; Amin C; Cangany M; Konig H; Cripe LD; Leukemia research 2014 Dec 2
Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy.
Sayar H; Sharfuddin AA; Taber TE; Mehta R; Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2011 Oct
Sayar H; Sharfuddin AA; Taber TE; Mehta R; Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2011 Oct
A noncanonical Flt3ITD/NF-?B signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Baghdadi TA; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS; Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Nov 17
Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Baghdadi TA; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS; Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Nov 17
Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: a study of the Hoosier Oncology Group.
Sayar H; Chan RJ; Orschell CM; Chan EM; Yu Z; Hood D; Plett A; Yang Z; Hui CL; Nabinger SC; Kohlbacher KJ; West ES; Walter A; Sampson C; Wu J; Cripe LD; Leukemia research 2011 Mar 21
Sayar H; Chan RJ; Orschell CM; Chan EM; Yu Z; Hood D; Plett A; Yang Z; Hui CL; Nabinger SC; Kohlbacher KJ; West ES; Walter A; Sampson C; Wu J; Cripe LD; Leukemia research 2011 Mar 21
Tumor MET expression may not predict the risk of venous thromboembolism in cancer patients.
Sayar H; Bunning JT; Bocklage TJ; Lee SJ; Libby E; Rabinowitz I; Oncology research 2010
Sayar H; Bunning JT; Bocklage TJ; Lee SJ; Libby E; Rabinowitz I; Oncology research 2010
Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies.
Sayar H; Shen Z; Lee SJ; Royce M; Rabinowitz I; Lee F; Smith H; Eberhardt S; Maestas A; Lu H; Verschraegen C; Investigational new drugs 2008 Sep 5
Sayar H; Shen Z; Lee SJ; Royce M; Rabinowitz I; Lee F; Smith H; Eberhardt S; Maestas A; Lu H; Verschraegen C; Investigational new drugs 2008 Sep 5
American Board of Internal Medicine - Hematology
Oncology
American Board of Internal Medicine - Internal Medicine
Leukemias, myelodysplastic syndrome, lymphomas
Org:
Desc: Trustee Teaching Award
Scope: University
Date: 2017-05-01
Desc: Trustee Teaching Award
Scope: University
Date: 2017-05-01
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.